NRTIs form the backbone of almost every HIV treatment regimen. Two medicines from this class are usually paired together and then combined with an anchor medicine from a different class. This guide explains what NRTIs are, how they work, which members of the class are used in India, and the safety points a treating doctor keeps under review.
NRTI stands for nucleoside reverse transcriptase inhibitor, a name that describes the enzyme these medicines act upon.
Important note
|
Quick Summary / Key Takeaways
|
NRTIs are a class of antiretroviral medicine that interferes with reverse transcriptase, the enzyme HIV uses to convert its genetic material into a form that can be copied. By supplying a faulty building block, NRTIs bring that copying process to a halt. The wider picture of how classes work together is set out in what is ART (antiretroviral therapy).
A regimen normally pairs two NRTIs and adds an anchor medicine, most often an integrase inhibitor. The pairing gives a broad and reliable foundation, while the anchor blocks a separate stage of the viral life cycle. This structure is described in first-line ART regimens explained.
| Medicine | Typical place in treatment | Key monitoring point |
| Tenofovir (TDF or TAF) | Backbone of most first-line regimens | Kidney function and bone health |
| Lamivudine | Paired with tenofovir or abacavir | Generally very well tolerated |
| Emtricitabine | Closely related to lamivudine, used similarly | Generally very well tolerated |
| Abacavir | Alternative backbone in specific cases | HLA-B*5701 test required before use |
| Zidovudine (AZT) | An older option used in particular situations | Blood counts, including anaemia |
Tenofovir comes in two forms, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF). Both deliver the same active medicine but behave differently in the body, which affects monitoring. The comparison is set out in tenofovir: TDF vs TAF explained.
These two medicines are closely related and are used in a similar way, generally as the partner to tenofovir or abacavir. Both are known for being well tolerated. Lamivudine is covered in lamivudine: uses and side effects.
Abacavir is an alternative backbone medicine, and a genetic test known as HLA-B*5701 is carried out before it is used, as explained in abacavir: uses, side effects and safety testing. Zidovudine is one of the oldest antiretroviral medicines and is now used in more limited circumstances, described in zidovudine (AZT): uses and side effects.
Modern NRTIs are generally well tolerated. Where effects occur, they are often mild and early, and may include nausea, headache, or tiredness. Each medicine also has its own particular considerations, which is why the choice within the class is made individually.
| Myth | Fact |
| All NRTIs are interchangeable. | They share a mechanism but differ in tolerability and monitoring needs. |
| One NRTI alone is enough. | Two NRTIs are normally paired, with an anchor medicine from another class. |
| Older NRTIs are never used now. | Some remain useful in particular situations decided by a doctor. |
| NRTIs work on the same stage as integrase inhibitors. | They act on a different enzyme and an earlier stage. |
| Monitoring is the same for every NRTI. | Each medicine has its own monitoring points. |
Medical advice is appropriate before starting or changing any NRTI, where side effects appear or persist, and where kidney, bone, or blood-related concerns arise during treatment. Routine monitoring is arranged through HIV lab testing.
NRTIs stop HIV from copying its genetic material, and a pair of them forms the backbone of nearly every regimen. Tenofovir with lamivudine or emtricitabine is the most common pairing, while abacavir and zidovudine have their own defined roles. Each medicine carries its own monitoring points, which is why selection within the class rests with the treating doctor.
NRTIs, or nucleoside reverse transcriptase inhibitors, are a class of HIV medicine that blocks reverse transcriptase, the enzyme HIV uses to copy its genetic material. They supply a faulty building block that halts the copying process.
Tenofovir paired with lamivudine or emtricitabine is the most common backbone. Abacavir and zidovudine are also part of the class and are used in particular situations decided by a treating doctor.
Pairing two NRTIs provides a broad and reliable foundation for treatment. An anchor medicine from another class, usually an integrase inhibitor, is then added to block a separate stage of the viral life cycle.
Both are forms of tenofovir that deliver the same active medicine, but they behave differently in the body. This affects the monitoring of kidney function and bone health, so the choice is made by the treating doctor.
A genetic test known as HLA-B*5701 is carried out before abacavir is used. Where the result is positive, abacavir is not prescribed, because those individuals can experience a serious hypersensitivity reaction.
Zidovudine is one of the oldest antiretroviral medicines and is now used in more limited circumstances. Newer options are generally preferred, but a treating doctor may still select it in particular cases.
Modern NRTIs are generally well tolerated. Where effects occur they are often mild and early, such as nausea, headache, or tiredness, although each medicine has its own particular monitoring considerations.
No. HIV treatment always combines medicines so the virus is blocked at more than one stage. NRTIs are used as part of a complete regimen selected by a treating doctor.
+91 98925 15959
Before You Go
The HIV Test Kit Is Still FREE
A private HIV self-test, delivered in plain packaging. Result in 20 minutes, at home. No cost, no clinic visit, and a TAAL+ doctor on call whichever way it goes.
Offer valid only in India till 30 September 2026. T&Cs apply.
